This article is more than 6 month old.

Coronavirus news highlights: Canada approves Pfizer's COVID-19 vaccine; SEC seeks more data on vaccines from Bharat Biotech, Serum Institute

Mini

Coronavirus news highlights: India's COVID-19 caseload rose to 97.35 lakh on Wednesday, while the number of people who have recuperated from the disease crossed 92 lakh, pushing the national recovery rate to 94.66 percent, according to the Union health ministry. The total coronavirus cases mounted to 97,35,850 with 32,080 new infections being reported in a day, while the death toll rose to 1,41,360 with 402 new fatalities, data updated by the ministry at 8 am showed. The number of people who have recuperated from the disease surged to 92,15,581, pushing the national recovery rate to 94.66 percent, while the COVID-19 case fatality rate stood at 1.45 percent. The COVID-19 active caseload remained below four lakh for the third consecutive day. There are 3,78,909 active coronavirus infections in the country now which comprises 3.89 percent of the total caseload, the data stated.

Coronavirus news highlights: Canada approves Pfizer's COVID-19 vaccine; SEC seeks more data on vaccines from Bharat Biotech, Serum Institute
  • With that it's a wrap to the LIVE updates on the coroanvirus pandemic for today. Do join us tomorrow for all the top developments on the COVID-19 situation from India and around the world. Until then, stay safe and good night.  

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Expert committee seeks Phase II/III clinical trial from Serum Institute

    CDSCO's Subject Expert Committee, which is looking into the emergency use approval applications of Serum Institute and Bharat Biotech has sought more data from both pharma companies before it would give its recommendations of to the apex body. The expert committee has recommended that Serum Institute should submit the following data/information for further review: 

    1. Updated safety data of the Phase II/III clinical trial in the country. 
    2. Immunogenicity data from the clinical trial in UK and India. 
    3. The outcome of the assessment of UK-MHRA for grant of EUA.

    The SEC has asked Bharat Biotech to submit safety and efficacy data from ongoing Phase III clinical trial in India for further consideration.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Canada health regulator approves Pfizer's COVID-19 vaccine

    Canada's health regulator on Wednesday approved Pfizers COVID-19 vaccine. Health Canada posted on it is website that the vaccine made by U.S. drugmaker Pfizer and Germanys BioNTech is authorized. Canada is set to receive up to 249,000 doses this month and 4 million doses of the vaccine by March. The Canadian government has purchased 20 million doses of that vaccine, which requires people to receive two doses each, and it has the option to buy 56 million more. Health Canada is reviewing three other vaccine candidates, including one from Moderna.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Chhattisgarh reports 1,421 new cases, 13 deaths

    With the addition of 1,421 COVID- 19 cases and 13 deaths, Chhattisgarh's total case count rose to 2,51,120 and toll to 3,308 on Wednesday, a health official said. The number of recoveries rose to 2,28,304 after 160 patients got discharge from various hospitals, while 818 others completed their home isolation during the day. The state currently has 19,778 active cases, the official said. Raipur district reported 188 new cases, taking its total count to 48,247, including 678 deaths. Bilaspur recorded 131 new cases, Janjgir-Champa 126, Durg 117, Mahasamund 107 and Rajnandgaon 104 among other districts, he said. "Of the latest fatalities, five took place on Wednesday, four on Tuesday while four had taken place earlier," he added.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Another fatality takes COVID-19 death toll to 96 in UP's Muzaffarnagar

    One more person succumbed to COVID-19 in Uttar Pradesh's Muzaffarnagar district, pushing the death toll to 96, while 55 new cases brought the infection count to 7,348 on Wednesday, officials said. The 46-year-old coronavirus positive woman died at the Muzaffarnagar Medical College on Tuesday, they said. A jail inmate is also among the fresh COVID-19 cases, which brought active case count to 509 in the district. According to District Magistrate Selvakumari J, results of 981 samples were received on Wednesday. The DM said 33 more people recovered from the infection, taking the COVID-19 recovery count to 6,743 in the district.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: SC seeks replies of Centre, states on aspects of COVID-19 guidelines, fire safety in hospitals

    The Supreme Court Wednesday sought "detailed" response from the Centre as well as states on issues ranging from adhering to COVID-19 guidelines on wearing of face masks and social distancing norms to implementation of fire safety guidelines in hospitals and nursing homes across the country. The top court was hearing a suo motu case registered by it to ensure proper treatment of COVID-19 patients in hospitals and dignified handling of dead bodies there. Recently, it also took cognisance of the fire incident in a designated COVID-19 hospital in Gujarat's Rajkot in which several patients had died, raising the issue of lack of proper fire safety measures in hospitals across the country. A bench headed by Justice Ashok Bhushan asked Solicitor General Tushar Mehta, appearing for the Centre and the Gujarat government, to file detailed affidavits within three days on the issues such as enforcing of COVID-19 guidelines and fire safety measures in hospitals and nursing homes.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Pfizer seeks time from SEC for vaccine presentation

    Pfizer has requested the Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) to schedule a meeting on a later date as the pharma company's experts are not readily available to present their case before the committee. The SEC sought more data on safety and immunogenicity of the COVID-19 vaccine from Serum Institute and Bharat Biotech over their emergency use authorisation requests. The expert panel of Serum Institute and Bharat Biotech could not commit, when they would present the data, sources told CNBC-TV18. The next meet of the CDSCO's expert panel will be scheduled once the companies get provide the more data on the vaccine.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Gujarat reports 1,318 new COVID-19 cases, 13 deaths

    Gujarat's COVID-19 tally increased to 2,22,811 on Wednesday with the addition of 1,318 cases, the state health department said. The death toll due to the infection went up by 13 to 4,123, it said. A totalof 1,550 patients got discharge during the day, which pushed the recovery count in the state to 2,04,661, at the rate of 91.85 per cent, the department said in a release. The number of active cases in the state stood at 14,027 and 75 of the patients are on ventilators. Gujarat's COVID-19 figures are as follows: Positive cases 2,22,811; new cases 1,318; death toll 4,123; active cases 14,027 and people tested so far 84,32,094.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Lowest COVID-19 deaths in Delhi since Nov 1; effect of pandemic on decline, says Jain

    Delhi on Wednesday recorded 50 COVID-19 deaths, the lowest since November 1, Health Minister Satyendar Jain said and asserted that the national capital is emerging victorious in the battle against the coronavirus. In a series of tweets, he also said that for the first time in Delhi, more than 2,500 ICU beds are vacant for COVID-19 patients. Delhirecorded 2,463 fresh COVID-19 cases on Wednesday with over 72,000 tests being conducted, even as the positivity rate dropped to 3.42 percent,authorities said. Today overall positivity is 3.42% this is less than 5% for the last 8 days. TodayPCR positivity is 6.46%,PCR positivity is less than 10% for the last 8 days. "Less than 5000 cases for the last 12 days. Today's death numbers are lowest since 1 Nov. Continue to observe all precautions, Jain tweeted. In another tweet, he said, It is heartening to see that Delhi is emerging victorious in the battle against the virus. Delhi has, for the first time, more than 13,000 vacant COVID-19 beds in hospitals. Now the effect of the pandemic is on the decline, he added. In another tweet, he said, First time ever more than 2500 ICU beds are vacant for COVID patients.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: COVID-19: Haryana reports 26 deaths, 1,400 fresh cases

    Twenty-six more people succumbed to the coronavirus in Haryana, bringing the death toll to 2,650 on Wednesday, while 1,400 new cases pushed the state's infection tally to 2,48,079, according to a bulletin. The new fatalities included eight from Faridabad, five from Hisar and three each from Gurugram and Jhajjar, the state health department's daily bulletin said. Among the districts which reported a big spike in fresh COVID-19 cases included Gurugram (436) and Faridabad (218). The state has an active COVID-19 case count of 11,733 and a recovery rate of 94.20 per cent, according to the bulletin.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: 617 new COVID-19 cases in Punjab, death toll nears 5,000

    The death toll from COVID-19 rose to 4,980 in Punjab with 16 more fatalities, while 617 new cases raised the infection tally to 1,57,928 on Wednesday, according to a bulletin. Six new deaths linked to the novel coronavirus were reported from Jalandhar; two each from Mohali and Tarn Taran and one each from Barnala, Ludhiana, Pathankot, Patiala, Rupnagar and Sangrur, according to the medical bulletin. There are 7,325 active COVID-19 cases in the state, as of now, it said. Mohali reported 125 new cases, followed by 70 in Jalandhar and 64 in Amritsar. A total of 530 patients were discharged after recovering from the infection, taking the recovery count to 1,45,623, according to the bulletin. Twenty-two critical COVID-19 patients are on ventilator support while 155 are on oxygen support, the bulletin said. A total of 34,23,632 samples have been collected for COVID-19 testing so far in the state, it said.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: 17 more COVID deaths, 1,511 new cases in Rajasthan

    Rajasthan recorded 17 more fatalities due to the novel coronavirus on Wednesday, taking the death toll to 2,845, while the infection count rose to 2,85,627 with 1,511 fresh cases, according to a health department bulletin. The state has 19,792 active COVID-19 cases. A total of 2,63,350 people in Rajasthan have been discharged after recovering from the infection, the bulletin said. The death toll from the pandemic stands at 466 in Jaipur, followed by 259 in Jodhpur, 203 in Ajmer, 164 in Bikaner, 153 in Kota, 115 in Bharatpur, 105 in Udaipur and 99 in Pali. Among the fresh COVID-19 cases, 401 were registered in Jaipur, 205 in Jodhpur, 137 in Kota, 81 in Ajmer, 79 in Bhilwara, 75 in Udaipur and 61 each in Kota amd Nagaur, besides cases reported in other districts of the state.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Tripura's COVID-19 tally rises to 32,945 with 20 fresh cases

    Twenty more people tested positive for COVID-19 in Tripura on Wednesday, pushing the tally in the state to 32,945, a health department official said. The COVID-19 death toll remained 370 as no patient succumbed to the infection on Tuesday, he said. Tripura currently has 406 active coronavirus cases, while 32,146 people have recovered from the disease. Twenty-three patients have migrated to other states, the official said. As many as 62 patients were released from GB Pant hospital, the main referral hospital for COVID-19 in the state, on Tuesday. The state has so far conducted 5.45 lakh COVID-19 tests, including 2.10 lakh RT-PCR and 3.35 lakh rapid antigen tests, the official added.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: AP records 618 new COVID-19 cases,three deaths

    As many as 618 people tested positive for coronavirus in Andhra Pradesh on Wednesday, while another 785 recovered from the infection and three more died. According to the latest bulletin, the total number of positive cases now touched 8,73,457, recoveries 8,61,153 and deaths 7,045. The active cases numbered 5,259, the bulletin added. So far, 1.05 crore samples were tested for coronavirus at the rate of 1,97,956 per million population, turning out an overall positivity rate of 8.26 per cent. Only Krishna district continued to report fresh cases in excess of 100 while four others reported between 50 and 100. Eight districts added less than 50 new cases each in 24 hours.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: 4,981 fresh COVID-19 cases reported in Maharashtra, 75 deaths

    Maharashtra's COVID-19 tally on Wednesday rose to 18,64,348 as it recorded 4,981 new cases, a state health official said. With 75 new fatalities, the death toll reached 47,902, he said. A total of 5,111 patients were discharged from hospitals after treatment, taking the tally of recovered cases in the state to 17,42,191. There are 73,166 active patients in the state. Mumbai city reported 716 new cases during the day, which pushed its overall case count to 2,87,898, while its death toll rose to 10,929 with 15 deaths being reported during the day. The state has so far conducted 1,14,47,723 coronavirus tests. Maharashtra's COVID-19 figures are as follows: Positive cases: 18,64,348, new cases: 4,981, death toll: 47,902, discharged: 17,42,191, active cases: 73,166, people tested so far: 1,14,47,723.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Kerala records 4,875 fresh COVID-19 cases, 35 deaths

    Kerala reported 4,875 new positive cases on Wednesday and 35 COVID-19 related deaths, taking the caseload in the state to 6,49,571 and the death toll to 2,507. State health minister K K Shailaja said currently there are 59,923 active cases. "The state has tested 52,655 samples in the last 24 hours and thetest positivity rate is 9.26 per cent," the minister said in a release. A total of 67,55,630 samples have been sent for testing till now, she said. The minister said 4,230 people including 43 healthcare workers were infected through contact while the contact source of infection was not known for 508. According to the release,94 of those diagnosed with the disease are from outside the state. "At the same time, 4,647 patients have recovered from the disease.A total of 5,86,998 have so far been cured of the disease in the state," the minister said. The district-wise figures for the new cases are: Ernakulam 717, Malappuram 709, Kozhikode 656, Thrissur 511, Kottayam 497, Palakkad 343, Pathanamthitta 254, Kannur 251, Wayanad 241, Kollam 212, Alappuzha 194, Thiruvananthapuram 181, Idukki 57 and Kasaragod 52.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: CDSCO expert panel seeks more data on vaccines from Serum Institute, Bharat Biotech

    An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said. The application by the Indian arm of US pharmaceutical firm Pfizer was not taken up for deliberation on Wednesday as the firm sought more time for making presentation before the committee, they said. The applications of both Bharat Biotech and the Serum Institute of India are still under consideration, a source told PTI. While considering Serum Institute's application, the subject expert committee (SEC) of the CDSCO is learnt to have asked for updated safety data of phase-2 and phase-3 clinical trials in the country, immunogenicity data from the clinical trial in the UK and India, along with the outcome of the assessment of the UK Medicines and Healthcare products Regulatory Agency (MHRA), sources said.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Norway softens rules on quarantine for travellers from abroad

    Travellers to Norway will be able to undergo a mandatory ten-day quarantine in a place of their choosing if they can document that they can respect quarantine conditions, the Nordic country's justice minister said on Wednesday. Presently, all travellers to Norway must undergo a ten-day quarantine in a quarantine hotel chosen by local authorities if they cannot document that they own property in the Nordic country.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Call for mass testing in South Korea amid rising third wave of virus

    The governor of South Korea's most populous province called for mass testing for coronavirus on Wednesday, as daily new cases centered in the densely populated Seoul area held at levels unseen since the outbreaks began earlier this year. South Korea is suffering a third wave of coronavirus outbreaks, and over the past week new cases have been consistently around 600.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: If 50 pc ICU beds for COVID-19 patients vacant, need immediate review of order: HC to Delhi govt

    The Delhi High Court said on Wednesday that if around 50 percent of the ICU beds reserved in private hospitals for COVID-19 patients are lying vacant, the decision to retain 80 percent of ICU beds for coronavirus patients needs to be reviewed immediately. The high court's remark came on being apprised by the counsel for a private hospitals' association that out of 5,081 ICU beds reserved for COVID-19 patients, 2,360 were vacant as on Tuesday and that there was no justification of continuation of the Delhi government's September 12 order.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Both Bharat Biotech and Serum Institute to come back again to SEC with more data, trials info, documents

    Subject matter experts held the emergency use authorization of both Bharat Biotech and SII and asked the pharma manufacturers to come back with more data and information on trials. Sources told CNBC-TV18, "Their application was not considered at present due to inadequate data." However, this does not mean that their authorization was rejected.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Britain advises people with allergy history to avoid Pfizer vaccine

    Britain's medicine regulator has advised that people with a history of significant allergic reactions do not get Pfizer-BioNTech's vaccine after two people reported adverse effects, England's National Health Service (NHS) said on Wednesday. "As is common with new vaccines the MHRA (regulator) have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination," Stephen Powis, national Medical Director for the NHS, said. 

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Pfizer not to make its presentation today before SEC

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: UK medicine regulator to assess best dose regimen of Oxford/AstraZeneca COVID-19 vaccine

    Britain's medical regulator will examine all the data from trials of the COVID-19 vaccine developed by Oxford and AstraZeneca, including which dosing regimen is best to use, the regulator's chief executive said on Wednesday. "Our regulatory review is all encompassing. We will look at all available data," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), told lawmakers after a study showed the vaccine had efficacy of 62% for trial participants given two full doses, but 90% for a smaller sub-group given a half, then a full dose.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Oxford-Astrazeneca vaccine production has $100 mn potential: Wockhardt

    Global pharmaceutical and biotechnology company Wockhardt has received the bulk active pharmaceutical ingredient (API) for producing the Oxford-Astrazeneca vaccine at their UK plant and the company will be manufacturing fully finished vaccines for the UK government. Speaking in an interview to CNBC-TV18, Habil F Khorakiwala, Founder, Chairman & Group CEO of the company said his company will be producing 160 million doses in a year with a revenue potential of USD 100 million. Read more.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Serum Institute completes presentation before SEC for emergency use approval of vaccine

    CNBC-TV18 has reported that Serum Institute of India has complete its presentation before the Subject Expert Committee of the Drugs Controller General of India (DCGI) for emergency use of its vaccine on December 9. The next presentation is being made by Bharat Biotech. It was earlier reported that Pfizer and Serum Institute had sought emergency use approval for their respective COVID-19 vaccines from the DCGI and an internal review was initiated under an accelerated review process. The review is expected to be conclude within two weeks, sources added. A day later Bharat Biotech had also filed an application for the emergency use approval of its vaccine in India.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Serum Institute completes it's presentation before Subject Expert committee (SEC), Bharat Biotech begins

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Sore eyes common vision-based indicator of COVID-19, study finds

    Sore eyes are the most significant vision-based indicator of COVID-19, according to a study led by an Indian-origin scientist which provides more understanding of how the novel coronavirus travels through the body. Researchers at Anglia Ruskin University (ARU) in the UK asked people who had a confirmed COVID-19 diagnosis to complete a questionnaire about their symptoms, and how those compared to before they tested positive.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Army reaches out to 350 families with ration in J-K
    The Indian Army on Wednesday distributed ration and medical kits among 350 families living in remote and snow-hit mountainous areas of Jammu and Kashmir's Ramban district. The army also conducted a medical and veterinary camp in Sumber panchayat, benefitting hundreds of nomadic Gujjar and Bakerwal community, a defence spokesperson said. Amid a pandemic, he said the army unit in Ramban district carried out distribution of ration and medical kits to 350 families residing in the areas of Sumbar, Dagnari, Banj, Bajon and Malpatti in consonance with its programme 'Corona Mukt Awam'. The kit contains basic essential day to day needs of the people residing in remote and higher reaches of Ramban, the spokesman said, adding at present the people residing in these areas are deprived of basic facilities due to remoteness of the location and rugged terrain," the spokesperson said.

    • Whats app
    • Telegram
  • Coronavirus News LIVE Updates: Over 60 foreign envoys visit leading pharma companies in Hyderabad
    Over 60 foreign envoys on Wednesday visited Hyderabad-based leading biotech companies Bharat Biotech and Biological E where they were apprised of India's vaccine development programmes in the wake of the COVID-19 pandemic. "In a first, a visit of more than 60 Heads of Missions was arranged to the research and manufacturing facilities of the leading biotechnology companies, Bharat Biotech and Biological E, in Hyderabad," Spokesperson in the Ministry of External Affairs Anurag Srivastava tweeted. Dr Krishna Ella, chairman and managing director of Bharat Biotech International Ltd, made a presentation to the foreign heads of missions on various aspects of vaccine production in India, sources said. In the presentation, the envoys were conveyed that 33 percent of global vaccines are produced in genome valley in Hyderabad, they said.

    • Whats app
    • Telegram
Coronavirus News LIVE Updates: India's COVID-19 caseload rose to 97.35 lakh on Wednesday, while the number of people who have recuperated from the disease crossed 92 lakh, pushing the national recovery rate to 94.66 percent, according to the Union health ministry. The total coronavirus cases mounted to 97,35,850 with 32,080 new infections being reported in a day, while the death toll rose to 1,41,360 with 402 new fatalities, data updated by the ministry at 8 am showed. The number of people who have recuperated from the disease surged to 92,15,581, pushing the national recovery rate to 94.66 percent, while the COVID-19 case fatality rate stood at 1.45 percent.
The COVID-19 active caseload remained below four lakh for the third consecutive day. There are 3,78,909 active coronavirus infections in the country now which comprises 3.89 percent of the total caseload, the data stated.
India's COVID-19 tally had crossed 20 lakh on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28 and 70 lakh on October 11. The figure crossed 80 lakh on October 29 and surpassed 90 lakh on November 20.
According to the Indian Council of Medical Research (ICMR), 14,98,36,767 samples have been tested up to December 8, with 10,22,712 such examinations being conducted on Tuesday.
The new fatalities include 57 from Delhi,53 from Maharashtra, 49 from West Bengal, 31from Kerala, 30 from Punjab, 23 from Uttar Pradesh and 20 from Rajasthan.
The total number of deaths reported so far in the country includes 47,827 from Maharashtra, 11,880 from Karnataka, 11,822 from Tamil Nadu, 9,763 from Delhi,8,820from West Bengal, 7,967 from Uttar Pradesh, 7,042 from Andhra Pradesh and 4,964 from Punjab.
The health ministry stressed that more than 70 percent of the deaths occurred due to comorbidities.
"Our figures are being reconciled with the ICMR," the ministry said on its website, adding that state-wise distribution of figures is subject to further verification and reconciliation.
Serum Institute of India, Pfzier, and Bharat Biotech were present before the Subject Expert Committee of the Drugs Controller General of India (DCGI) for emergency use of its vaccine on December 9.
While Pfizer did not go ahead with the presentation, Bharat Biotech and SII did. According to CNBC-TV18 sources, Subject matter experts held the emergency use authorization of both Bharat Biotech and SII and asked the pharma manufacturers to come back with more data and information on trials. Sources told CNBC-TV18, "Their application was not considered at present due to inadequate data." However, this does not mean that their authorization was rejected.
It was earlier reported that Pfizer and Serum Institute had sought emergency use approval for their respective COVID-19 vaccines from the DCGI and an internal review was initiated under an accelerated review process. The review is expected to be conclude within two weeks, sources added. A day later Bharat Biotech had also filed an application for the emergency use approval of its vaccine in India.
Catch all the latest updates and developments from the pandemic today:

Market Movers

CompanyPriceChange%Loss
ONGC120.25 -4.85
Coal India146.40 -5.75
JSW Steel670.60 -25.75
NTPC113.55 -3.85
UPL808.00 -27.05
CompanyPriceChange%Loss
ONGC120.35 -4.65
NTPC113.55 -3.70
M&M784.85 -20.60
Power Grid Corp233.00 -6.70
Nestle17,678.30 -375.20
CompanyPriceChange%Loss
ONGC120.25 -4.85 -3.88
Coal India146.40 -5.75 -3.78
JSW Steel670.60 -25.75 -3.70
NTPC113.55 -3.85 -3.28
UPL808.00 -27.05 -3.24
CompanyPriceChange%Loss
ONGC120.35 -4.65 -3.72
NTPC113.55 -3.70 -3.16
M&M784.85 -20.60 -2.56
Power Grid Corp233.00 -6.70 -2.80
Nestle17,678.30 -375.20 -2.08

Currency

CompanyPriceChng%Chng
Dollar-Rupee73.8600-0.2175-0.29
Euro-Rupee87.8770-0.4200-0.48
Pound-Rupee102.2970-0.9290-0.90
Rupee-100 Yen0.6699-0.0019-0.29